Harmony Asset Management LLC Novo Nordisk A S Transaction History

Harmony Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$58.08 - $81.05 $358,934 - $500,889	-6,180 Reduced 43.89%	7,900 $545 Million
Q1 2025 May 01, 2025	SELL	$69.3 - $90.95 $3.31 Million - $4.34 Million	-47,697 Reduced 77.21%	14,080 $978 Million
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $80,750 - $114,038	950 Added 1.56%	61,777 $5.31 Billion
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $368,375 - $441,023	3,002 Added 5.19%	60,827 $8.68 Billion
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $81,688 - $108,735	-800 Reduced 1.36%	57,825 $7.42 Billion

Q4 2023 Feb 08, 2024	BUY	$87.78 - $105.45 $5.15 Million - $6.18 Million	58,625 New	58,625 $6.06 Billion

1,686

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Harmony Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harmony Asset Management LLC with notifications on news.